|
Wed, 09/09/2020 - 01:46 |
New School Year Can Bring Stress and Headaches for Children |
Piedmont Henry ... |
|
Fri, 01/04/2019 - 04:24 |
DPH Announces First Flu Deaths of the 2018-2019 Season; Officials Remind Delawareans to Get Vaccinated |
Delaware State ... |
|
Thu, 12/13/2018 - 07:03 |
New Grand Rapids health clinic offers osteopathic manipulative medicine |
Michigan State ... |
|
Wed, 12/05/2018 - 21:55 |
FDA Approves Genentechs Tecentriq in Combination With Avastin and Chemotherapy for the Initial Treatment of People With a Specific Type of Metastatic Lung Cancer |
Genentech |
|
Tue, 12/04/2018 - 12:48 |
UCLA scientist looks to space for possible treatment of some neurological diseases |
UCLA |
|
Mon, 12/03/2018 - 20:55 |
FDA Grants Priority Review to Genentechs Tecentriq in Combination With Chemotherapy for the Initial Treatment of Extensive-Stage Small Cell Lung Cancer |
Genentech |
|
Sat, 12/01/2018 - 05:02 |
Regeneron Presents Positive Data at ASH for REGN1979 CD20xCD3 Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma |
Regeneron |
|
Sat, 12/01/2018 - 01:20 |
Novartis announces longer-term analyses from pivotal Kymriah trials that showed durable responses are maintained in patients with advanced blood cancers |
Novartis |
|
Mon, 11/26/2018 - 20:32 |
Pfizer Receives Six Months Pediatric Exclusivity for LYRICA (pregabalin) |
Pfizer |
|
Sat, 11/24/2018 - 05:42 |
Breakers skipper continues incredible run |
Cricket NSW |
|
Fri, 11/23/2018 - 09:07 |
Everybody knows these Democrats will probably run for president - so why wont they say it? |
Campaign Legal ... |
|
Mon, 11/19/2018 - 18:26 |
New Guidance on Diagnosing and Reducing Period Pain Can Help Adolescents Thrive |
ACOG |
|
Fri, 11/16/2018 - 15:16 |
Study: Dow-funded Chlorpyrifos Research Omitted Results, Leading to Inaccurate Conclusion of Pesticide's Safety |
Center for Biol... |
|
Wed, 11/14/2018 - 11:29 |
VSP Optics Launches New Single-Vision Lens for Digital Eye Strain Relief |
VSP Vision Care |
|
Mon, 11/12/2018 - 10:37 |
FDA Grants Priority Review to Genentechs Tecentriq in Combination With Abraxane for the Initial Treatment of People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer |
Genentech |
|
Sun, 11/11/2018 - 23:08 |
Australian-first lab to improve treatment for brain-injured children |
QueenslandUniv |
|
Fri, 11/09/2018 - 09:11 |
FLU SEASON UPDATE: FLU ACTIVITY IN DELAWARE REMAINS LOW. OFFICIALS CONTINUE TO RECOMMEND FLU VACCINATION. |
DHSS |
|
Fri, 11/09/2018 - 05:14 |
Flu Season Update: Flu Activity in Delaware Remains Low. Officials Continue to Recommend Flu Vaccination |
Delaware State ... |
|
Thu, 11/01/2018 - 23:49 |
Traumatic Brain Injuries Can Lead to Long-Term Neurological and Psychiatric Disorders |
American Academ... |
|
Wed, 10/31/2018 - 00:22 |
Nearly 200 UCLA volunteers treat the uninsured at the annual Care Harbor free clinic |
UCLA |
|
Mon, 10/29/2018 - 17:56 |
Why Its Important to Talk to Your Kids About Bullying |
Cone Health |
|
Tue, 10/23/2018 - 09:09 |
Opioid Policies Based On Morphine Milligram Equivalents Are Automatically Flawed |
American Counci... |
|
Mon, 10/22/2018 - 09:34 |
Genentechs Tecentriq Plus Chemotherapy (Carboplatin and Abraxane) as an Initial Treatment Helped People With Advanced Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone |
Genentech |
|
Mon, 10/22/2018 - 05:34 |
Novartis COMBI-AD study of Tafinlar + Mekinist continues to demonstrate relapse free survival benefit in patients with BRAF V600-mutant stage III melanoma |
Novartis |
|
Fri, 10/19/2018 - 21:22 |
Genentechs Tecentriq in Combination With Abraxane Improves Outcomes as an Initial Treatment for People With PD-L1-Positive Metastatic Triple-Negative Breast Cancer |
Genentech |
